Background
==========

Cause-specific mortality data on childhood deaths are vital to identify health needs, compare patterns of death across populations, plan and monitor interventions, and inform policy \[[@B1]-[@B3]\]. In high-income countries, all births and deaths are enumerated through vital registration systems, and death certification is routine. In low-income settings, most births and deaths occur at home, death certificates are rarely available, and vital registrations are often inadequate or nonexistent \[[@B2]-[@B4]\].

Verbal autopsies (VAs) provide an alternative means of identifying probable causes of death through interviews with a close caregiver of the deceased, in which information about the circumstances, signs, and symptoms leading to death are gathered. VAs have limitations: they require recollection of events at the time of death, rely on understanding and reporting of signs and symptoms by interviewees, and may be influenced by interviewer skills. The data must also be interpreted to establish a diagnosis \[[@B5]\]. Conventionally, VA questionnaires are read by two or more physicians separately and one or more causes of death are attributed. A cause of death is established when physicians\' opinions correspond; otherwise diagnosis is reconsidered and discussed with or without the input of an additional physician. If no agreement is reached, the cause of death is considered undetermined. Repeatability of this diagnostic process over time and in different settings is problematic, particularly when diagnostic criteria are not standardized amongst different clinicians \[[@B6]-[@B8]\]. In some situations, disagreement between physicians is such that a large proportion of causes of death remain indeterminate \[[@B7],[@B9]\]. Moreover, the method is costly, time-consuming, and requires the involvement of physicians who are an already overstretched resource in low-income countries \[[@B6],[@B10]\].

Despite these limitations, VAs are useful in estimating cause-specific mortality fractions (CSMFs) in population studies \[[@B6],[@B8],[@B11]\]. They have been used extensively in epidemiological studies, household surveys, and sentinel surveillance sites, and have been piloted in subsamples from sample registration systems. There remains a need to refine the technique to make it more comparable, repeatable, easy to apply, and cost-effective.

VA questionnaires devised by the WHO attempt to standardize the interview process, but more standardized approaches to interpreting VA data are needed. Hierarchical algorithms and computer programs based on logistic regression have been used, but they are difficult to standardize across cultures and age groups and can usually only identify single causes of death \[[@B12],[@B13]\]. InterVA uses a probabilistic method and has been tested in a range of settings for deaths at all ages, across sexes, and for maternal deaths \[[@B14],[@B15]\].

We describe the refinement and evaluation of InterVA to identify causes of death in the perinatal (stillbirths and neonatal deaths in the first seven days) and neonatal periods, using data from three different settings: Malawi, Zimbabwe, and Nepal.

Methods
=======

Based on Bayes\' theorem \[[@B16]\], the InterVA model calculates the probability of a set of causes of death given the presence of circumstances, signs, and symptoms (collectively called \'indicators\') reported in VA interviews. The method is described in detail elsewhere \[[@B10],[@B17]\]. Briefly, a finite number of causes of death are assigned to a predefined matrix of estimated probabilities of occurrence. The presence of indicators (Table [1](#T1){ref-type="table"}) modifies the predefined probabilities of each cause of death upward or downward using Bayes\' theorem according to the formula

###### 

InterVA indicators and cause of death categories.

  Indicators                                Cause of Death Categories                 
  ----------------------------------------- ----------------------------------------- -----------------------------------------------------------
  was this an elder 65+ years               any chronic/recurrent diarr (4+w)         Perinatal asphyxia
  was this an adult 50-64 years             any abdominal swelling                    Congenital malformation
  was this a female 15-49 years             any vomiting                              Prematurity
  was this a male 15-49 years               any yellowness/jaundice                   Tetanus
  was this a child 5-14 years               any abnormality of urine                  Pneumonia
  was this a child 1-4 years                any urinary retention                     Malaria
  was this an infant 4 wks-1 yr             any haematuria                            Measles
  was this a neonate \< 4 wks               any swelling of ankles/legs               Meningitis
  was she pregnant at death                 no bilateral swelling of ankle            Diarrhea
  did pregnancy end within 6 weeks          any skin lesions/ulcers                   Bloody diarrhea
  did final illness last at least 3 weeks   any rash (non-measles)                    Other acute infection
  did final illness last \< 3 weeks         any herpes zoster                         Malnutrition
  was death very sudden/unexpected          any measles rash                          Kwashiorkor
  was death during wet season               any excessive night sweats                HIV/AIDS related
  was death during dry season               any excessive water intake                Pulmonary tuberculosis
  was s/he in a transport accident          any excessive urination                   Chronic infection
  did s/he drown                            any excessive food intake                 Maternal causes
  had s/he fallen recently                  any acute fever                           Acute respiratory disease (not pnem.)
  any poisoning, bite, sting                any persistent fever (\> 2 wk)            Chronic respiratory disease
  was s/he a known smoker                   any enlarged/swollen glands               Acute cardiac
  any obvious recent injury                 any facial swelling                       Chronic cardiac
  was s/he known to drink alcohol           was there a coma \> 24 hrs                Stroke
  any suggestion of homicide                any weight loss                           Diabetes
  any convulsions or fits                   any anaemia/paleness                      Malignancy
  any diagnosis of epilepsy                 any drowsiness                            Liver disease
  was the fontanelle raised                 any delayed/regressed development         Kidney disease
  was the fontanelle or eyeball sunken      any diagnosis of asthma                   Disorders of the digestive system
  any headache                              any diagnosis of diabetes                 Diseases of the nervous system
  was there paralysis on both sides         any diagnosis of heart disease            Sickle cell anemia
  any paralysis/weakness on 1 side          any diagnosis of HIV/AIDS                 Transport-related accident
  any stiff neck                            any diagnosis of hypertension             Accidental poisoning
  any oral candidiasis                      been discharged from hospital very ill    Accidental drowning
  any rigidity/lockjaw                      any suggestion of suicide                 Other accident
  abnormal hair coloring                    any surgery just before death             Homicide
  any coughing with blood                   any diagnosis of TB                       Suicide
  any chest pain                            was s/he adequately vaccinated            
  was there a cough for \> 3 wks            any diagnosis of liver disease            **Additional indicators**
  was there a cough for up to 3 wks         any diagnosis of cancer                   **did baby have arched back after 2 days**
  any productive cough                      any diagnosis of stroke                   **baby stopped sucking after day 3**
  any rapid breathing                       any diagnosis of measles                  **did the baby die on day 1**
  any breathlessness on exertion            any diagnosis of kidney disease           **did the mother fail to receive tetanus toxoid vaccine**
  any breathlessness lying flat             any diagnosis of hemoglobinopathy         **did convulsions happen on day 1**
  any chest indrawing                       any diagnosis of malaria                  **was there no cry/move/breath at birth**
  any difficulty breathing                  any delivery complications                **was baby\'s skin puffy/mushy at birth**
  any breast lump or lesion                 any heavy bleeding around delivery        **did the baby fail to cry at birth**
  any wheezing                              was there prolonged labor \> 24 hrs       
  any cyanosis                              were there convulsions during delivery    
  any abdominal mass                        was the baby born early \< 34 wks         **Additional causes of death**
  any abdominal pain                        was the baby small \< 2500 g              **Fresh stillbirth**
  any diarrhea with blood                   was there difficulty breathing at birth   **Macerated stillbirth**
  any vomiting with blood                   any congenital malformations              
  any acute diarrhea (\< 2 wks)             was this a multiple birth                 
  any persistent diarrhea (2-4 wks)         any umbilical infection                   

Indicators added following refinement of InterVA for neonatal deaths are highlighted in bold.

where p (C\|I) indicates the probability of a cause of death (C) given the presence of the indicator (I) and p(I/!C) is the probability of I in the absence of C \[[@B10]\].

Probabilities of final-cause categories increase or decrease in relation to specific signs and symptoms reported in the VA interview. If symptoms are not reported, the probabilities do not change. The program is available online <http://www.InterVA.net>. Users can enter the data as single cases or in batches, and the model generates up to three causes of death and their respective likelihoods. Prior to the current study, the probability matrix consisted of 34 cause of death classifications and 104 indicators \[[@B10]\].

Data sources
------------

To explore the performance of InterVA in different settings, 734 stillbirth and neonatal VAs were obtained from rural areas of three low-income countries.

In Malawi (Mchinji District), 169 stillbirth and neonatal VAs were collected from 2004 to 2005, as part of a cluster-randomized study evaluating two community interventions to improve maternal and child health \[[@B18]\]. Although designed for the study, the VA questionnaire was comparable in structure and content with the subsequent WHO questionnaire \[[@B19]\]. Completed questionnaires were interpreted independently by two Malawian pediatricians, who assigned up to three causes of death on the basis of a hierarchical classification and algorithm \[[@B20]\]. They were able to use alternative diagnoses where necessary. Discrepancies were resolved by discussion and, if consensus could not be reached, the cause of death was recorded as indeterminate.

In Nepal (Makwanpur district), 385 VAs were collected from 2001 to 2003 as part of a cluster-randomized study of a community intervention to improve maternal and child health \[[@B21]\]. The questionnaire was again comparable with the subsequent WHO tool. Questionnaires were interpreted independently by two Nepalese pediatricians, who each assigned a single cause of death on the basis of the same algorithm used in Malawi. Discrepancies were resolved after review by a third physician.

The third data source included 180 neonatal deaths from Zimbabwe, identified as part of a maternal and perinatal mortality study conducted in 2007 and 2008\[[@B22]\]. Neonatal VAs were conducted using the WHO tool. Questionnaires were interpreted independently by two physicians, who each assigned a single cause of death using the International Classification of Diseases and Related Health Problems (ICD-10). Discrepancies were resolved after review by a third physician (Table [2](#T2){ref-type="table"}).

###### 

Characteristics of the three studies used as data sources.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                    Malawi                                                 Nepal                                Zimbabwe
  --------------------------------- ------------------------------------------------------ ------------------------------------ --------------------------------------------------------------------------------
  **Neonatal mortality rate**       27/1000\[[@B30]\].                                     33/1000\[[@B31]\]                    24/1000\[[@B32]\]

                                                                                                                                

  **Study period**                  1 year                                                 3 years                              2 years

                                                                                                                                

  **Number of VA questionnaires**   169                                                    385                                  180

                                                                                                                                

  **Questionnaire**                 Mixed open and closed questions                        Mixed open and closed questions      Standard WHO tool incorporating open and closed questions (24)

                                                                                                                                

  **Interviewers**                  5 lay Malawian interviewers with secondary education   Lay local field coordinators         45 midwife enumerators

                                                                                                                                

  **Physician review**              2 experienced local pediatricians\                     3 experienced local pediatricians\   3 experienced local physicians\
                                    Predefined algorithm\                                  Predefined algorithm\                International Classification of Diseases and Related Health Problems (ICD-10)\
                                    3 causes of death                                      1 cause of death                     1 cause of death
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Refining InterVA
----------------

Initial refinement of the InterVA model was based on 100 (59%) physician-reviewed VAs from Malawi. The use of these data for refinement was pragmatic in that, at the time of refinement, they were the only data available. Data from the VA questionnaire were entered in the InterVA model, which assigned causes of death and associated likelihoods. The open histories, where the caregiver reported the events leading to death, were coded and also entered in the model. CSMFs obtained using the original InterVA and physician review were compared. CSMFs were calculated from the InterVA output as the sum of the likelihoods computed for each single cause of death category, divided by the sum of the likelihoods for all causes. For the calculation of CSMFs from physician-review data, if more than one cause of death was assigned, each was considered as a proportion of the total death. Therefore, if a single cause of death was assigned by all physicians, or if only one was available, it explained 100% of that death. If more than one cause of death was attributed, each contributed an equal proportion of the total 100%. For example, if both reviewing physicians assigned prematurity as a cause of death and one of them also assigned sepsis, then prematurity contributed 75% and sepsis 25% to the death. In this way, every available physician diagnosis contributed to the cause-specific mortality profile, avoiding a potential loss of information and bias that might have been introduced by using consensus diagnoses alone.

Fifty-four neonatal-death questionnaires were analyzed with the original InterVA model. Stillbirths were initially excluded, as InterVA was not designed to classify them. The results of this first analysis identified the need for greater differentiation in the model among causes of death in the neonatal period. The InterVA indicators and matrix probabilities were therefore reviewed for clinical and epidemiological coherence by a pediatrician-researcher (SV) and an epidemiologist involved in the development of InterVA (EF). Following this initial refinement, InterVA was evaluated by comparing case-by-case diagnoses with physician-assigned diagnoses for the same 100 VA cases, as well the population-level CSMFs. A process of refinement and comparisons with physician review was undertaken until InterVA elicited mortality profiles deemed by the researchers to be plausible and satisfactorily comparable to physician review.

Evaluating the refined InterVA model
------------------------------------

The modified InterVA model was evaluated by comparing population-level CSMFs derived from the two methods of interpretation (physician review and InterVA) for a further and hitherto-untouched 69 VAs from Malawi, 385 from Nepal, and 180 from Zimbabwe. A diversity of data sources was chosen to assess the performance of InterVA in a range of settings. Comparisons of population-level CSMFs were considered paramount as InterVA is intended as a public health tool for health monitoring and program evaluation, rather than for use in clinical settings. Nevertheless, individual level, case-by-case comparisons between physician diagnoses and InterVA were also conducted and the kappa statistic for interrater agreement was calculated to further evaluate the InterVA against the only available alternative method in our populations \[[@B23]\].

Ethical considerations
----------------------

The Maimwana study (Malawi) received ethical approval from the Malawi National Health Sciences Research Committee; the MIRA Makwanpur, Nepal, study was approved by the Nepal Health Research Council and the Institute of Child Health and Great Ormond Street Hospital ethics committees; and the Zimbabwe Maternal and Perinatal Mortality Study received ethical approval from the Medical Research Council of Zimbabwe (MRCZ/A/1368).

Results
=======

Refining InterVA
----------------

InterVA was modified to include two extra cause of death categories: fresh stillbirth and macerated stillbirth. To define the stillbirth diagnoses and differentiate among possible causes of stillbirth and neonatal death, nine further indicators were added to the model. The resulting modifications to the specific indicators and cause of death categories included in InterVA are shown in Table [1](#T1){ref-type="table"}. As these are extra entities in the model, they run in parallel to the existing indicators and causes without directly affecting them.

To compare the InterVA output and physician diagnoses in the three settings, some rationalization between the physician-assigned causes and the causes obtained from InterVA was necessary; therefore, causes of death not included in the InterVA classification were grouped as \"other.\" Similarly, infectious causes of neonatal deaths, including sepsis, pneumonia, and meningitis were grouped together into an \"infection\" category, since the possibilities of clinically distinguishing them in newborn infants is difficult. There were no cases of neonatal tetanus. The resulting CSMFs for InterVA and physician review of the 100 VA cases from Malawi used to refine the model are shown in Figure [1](#F1){ref-type="fig"}. In 73% of cases, at least one of the InterVA diagnoses agreed with at least one of the physician diagnoses (kappa 0.60 (95% confidence interval \[CI\]: 0.57, 0.70)).

![**Cause-specific mortality fractions from InterVA and physician review (PR) for the 100 VA cases from Malawi used to develop and refine the model**. Note to Figure 1: Other causes include \"jaundice,\" \"multiple pregnancies,\" \"maternal causes,\" \"hypothermia,\" and \"hypoglycemia.\"](1478-7954-9-48-1){#F1}

Evaluation of the Refined InterVA Model
---------------------------------------

After refining the model, case-by-case agreement between InterVA and reviewing physician diagnoses, for 69 cases from Malawi, 180 cases from Zimbabwe, and 385 cases from Nepal, was 83% (kappa 0.76 (0.75 - 0.80)), 71% (kappa 0.41(0.32-0.51)), and 74% (kappa 0.63 (0.60-0.63)), respectively.

CSMFs derived from InterVA and physician review in Malawi, Zimbabwe, and Nepal are illustrated in Table [3](#T3){ref-type="table"}. In Malawi and Zimbabwe, the rank order of causes of death was identical when derived from InterVA or physician review. In Nepal, the most common cause of death according to InterVA was perinatal asphyxia, while it was neonatal infections according to physicians. Prematurity was diagnosed more commonly by InterVA than by physicians in Nepal and Zimbabwe. InterVA detected a higher proportion of neonatal infections than physicians in Zimbabwe, but a lower proportion in Nepal.

###### 

Comparison of cause-specific mortality fractions according to InterVA and physician review.

  ---------------------------------------------------------------------------------------------------------------------------
                                 Malawi\          Nepal\        Zimbabwe\                                       
                                 69 VA            385 VA        180 VA                                          
  ------------------------------ ---------------- ------------- ---------------- ------------- ---------------- -------------
                                 **Physician**\   **InterVA**   **Physician**\   **InterVA**   **Physician**\   **InterVA**
                                 **review**                     **review**                     **review**       

                                                                                                                

  **Stillbirth**                 28.0             44.3          44.0             45.2          16.5             20.1

                                                                                                                

  **Perinatal asphyxia**         18.8             19.4          21.5             26.4          11.3             9.9

                                                                                                                

  **Neonatal infections**        23.3             26.0          28.0             20.4          30.6             44.5

                                                                                                                

  **Prematurity**                10.4             7.5           3.1              6.5           18.2             23.9

                                                                                                                

  **Congenital malformations**   2.2              1.3           0.8              0.9           1.3              0.4

                                                                                                                

  **Other**                      13.3                           1.6                            9.5              

                                                                                                                

  **Indeterminate**              4.0              1.5           1.0              0.6           12.8             1.3
  ---------------------------------------------------------------------------------------------------------------------------

Stillbirths
-----------

The proportion of total stillbirths identified by the two methods of VA interpretation was similar in all three settings. Data from Malawi and Nepal allowed for a more detailed comparison of the relative proportions of fresh and macerated stillbirths (Table [4](#T4){ref-type="table"}).

###### 

Fresh/macerated split of stillbirths from Malawi and Nepal based on interpretation by InterVA and physician review.

  --------------------------------------------------------------------------------
                     Malawi\          Nepal\                         
                     169 VA           385 VA                         
  ------------------ ---------------- ------------- ---------------- -------------
                     **Physician**\   **InterVA**   **Physician**\   **InterVA**
                     **review**                     **review**       

                                                                     

  Fresh              23.2             33.4          24.7             39.4

                                                                     

  Macerated          4.8              10.9          19.2             5.9

                                                                     

  Total Stillbirth   28.0             44.3          44.0             45.2
  --------------------------------------------------------------------------------

Multicountry mortality comparison
---------------------------------

Considering the above evaluations and taking the refined model to be adequate for the purposes of characterizing cause compositions of neonatal mortality for population health planning and monitoring, a three-country comparison of neonatal cause-specific mortality was conducted (Figure [2](#F2){ref-type="fig"}). It showed some differences in cause compositions of neonatal deaths, particularly in Zimbabwe compared to the other two settings. In Zimbabwe, the proportions of preterm births and deaths due to infection were higher (44%) than in Malawi (28%) or Nepal (20%).

![**Neonatal death cause compositions from InterVA interpretation of VA data from 169 deaths in Malawi, 180 deaths in Zimbabwe, and 385 deaths in Nepal**.](1478-7954-9-48-2){#F2}

Discussion
==========

The deadline for the Millennium Development Goals (MDGs) is less than five years away and the need to quantify childhood mortality, understand its causes, and assess the effects of proposed interventions are central to MDG4. Neonatal deaths contribute about 40% of under-5 mortality globally \[[@B24]\]. A recent evaluation of the INDEPTH network of Health and Demographic Surveillance Sites \[[@B25]\] calls for all sites to use InterVA for coding of causes of death, since such approaches represent \"the only viable strategy to produce timely and comparable cause of death statistics\" \[[@B26]\]. Our study has revised the InterVA method for verbal autopsy to improve its ability to identify causes of stillbirth and newborn death and tested it in three populations.

In this study, physician review was used as a reference standard to compare InterVA. The use of physician review was the only alternative source of cause of death assessment for our study populations. This choice has limitations, however. Physicians are influenced by their experience, perception, and interpretation of local epidemiology \[[@B23],[@B27]\]. Moreover, they mostly use the open history to reach a decision and may not account consistently for all the indicators. Sensitivity and specificity of physician review compared with hospital diagnosis in neonatal populations varied between 64% and 74% in a recent study \[[@B20]\] and concerns about inter- and intrarater reliability are well described \[[@B23]\].

An alternative to physician diagnoses is the use of hospital records. Hospital diagnoses have been used to establish sensitive, specific, and positive predictive values of VA diagnoses \[[@B8],[@B12],[@B20]\]. The main pitfall of hospital diagnoses in developing countries, particularly in rural settings, is that the CSMF of deaths occurring in hospitals are likely to be different from the ones in communities \[[@B23]\]. There is therefore the risk of increasing precision of an interpretative method, defined as its ability to reproduce hospital diagnoses in the population where it is tested. This would not necessarily produce results that are correct when used in populations where access to hospitals and health care is limited. Moreover, the ability to recognize, recall, and report signs of illnesses may be different among hospital users and nonhospital users.

The results of InterVA as compared with physician review showed an almost identical ranking of causes of death. However, differences exist. Some of these differences can be explained by the way the model was constructed. Prematurity, for example, was over-diagnosed by InterVA in Zimbabwe and Nepal. This probably resulted from using a dataset where clinicians were allowed more than a single cause of death to refine InterVA. In fact, when multiple causes of death are allowed, prematurity is more likely to be listed as a coexisting cause of death than when a single cause is selected \[[@B28]\]. The model did not include \"other\" as a cause of death and would have classified such causes of death in one of the available diagnoses.

InterVA over-diagnosed neonatal infections compared with physician review in Zimbabwe, while the opposite happened in Nepal. This inconsistency could be due to the interpretation of signs by different physicians. Alternatively, it could be due to the selection of *a priori*probabilities. Greater understanding of the way physicians decide to value or ignore signs and symptoms may help in future refinements and evaluations of InterVA.

Stillbirths were included for practical and public health reasons. Although globally there are about 3.2 million stillbirths per year, reliable statistics are lacking \[[@B29]\]. This information gap has to be addressed. About half of perinatal deaths are accounted for by stillbirths \[[@B29]\]. The refinements including stillbirths in the model eliminate the need to differentiate between live births and stillbirths before processing VA data, making the method more suitable for use in large surveys. The separation between fresh and macerated stillbirths is relevant, as prevention strategies are different. The comparisons between InterVA and physician review in Malawi and Nepal suggest that InterVA can differentiate the two categories, although, as with neonatal deaths, there may be room for further refinement.

Case-by-case agreement was moderate in all datasets, however it was lower for Zimbabwe compared to Nepal and Malawi. The new indicators and matrix probabilities have been chosen and modified on the basis of the personal experience of the researchers, and subsequently tested and modeled on a subset of the Malawi data. There is a risk, therefore, that the tool may be too closely modeled on a sub-Saharan African setting (although the results from Nepal do not support this) or on a particular research setup. In addition, the modifications have so far not been put to a panel of experts and may need to be subject to a wider consensus.

There may be important epidemiological and social explanations for the difference in the CSMF in Malawi, Zimbabwe, and Nepal. However, even if the interpretation of verbal autopsy data by InterVA was consistent, methodological variability in other aspects of VA may have contributed to the observed cause distribution. Indeed, the close comparability of CSMF between Malawi and Nepal may to some degree reflect common data capture processes that differ from those used in Zimbabwe. It is possible that in Nepal and Malawi, the populations were part of research areas and might have been sensitized to recognize, describe, and recall signs of neonatal diseases, while in Zimbabwe the community was part of a government surveillance and may have responded differently. Nevertheless, this is a reality of all VA studies conducted in research settings. Use of lay (in Malawi and Nepal) versus health-professional (in Zimbabwe) interviewers and their gender may also have had an impact on data capture. This highlights the need for further methodological research into the effects of other aspects of VA. It is likely that a number of strategies and international collaborations will be necessary to ensure the success of such investigations.

The modified version of InterVA for stillbirths and neonatal deaths produced plausible results when compared with physicians\' opinions but had the advantage of being completely internally consistent, allowing standardized comparisons of data from different countries. Ultimately, standardized methods are essential and their application and evaluation in a wide range of settings is encouraged. Through wider application, the strengths and weakness of InterVA, and VA in general, will become more apparent, thereby better informing the application and public health utility of surrogate methods for measuring mortality in absence of vital registration systems.
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